100 related articles for article (PubMed ID: 19422789)
1. APOE 4 polymorphism results in early cognitive deficits in an EAE model.
Tu JL; Zhao CB; Vollmer T; Coons S; Lin HJ; Marsh S; Treiman DM; Shi J
Biochem Biophys Res Commun; 2009 Jul; 384(4):466-70. PubMed ID: 19422789
[TBL] [Abstract][Full Text] [Related]
2. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.
Bour A; Grootendorst J; Vogel E; Kelche C; Dodart JC; Bales K; Moreau PH; Sullivan PM; Mathis C
Behav Brain Res; 2008 Nov; 193(2):174-82. PubMed ID: 18572260
[TBL] [Abstract][Full Text] [Related]
3. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
[TBL] [Abstract][Full Text] [Related]
4. Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: the role of kallikrein-kinin system.
Dutra RC; Moreira EL; Alberti TB; Marcon R; Prediger RD; Calixto JB
Brain Behav Immun; 2013 Oct; 33():90-101. PubMed ID: 23777652
[TBL] [Abstract][Full Text] [Related]
5. APOE epsilon4 allele is associated with cognitive impairment in patients with multiple sclerosis.
Mazurek AA; Shi J
Neurology; 2008 Oct; 71(15):1203; author reply 1203. PubMed ID: 18838671
[No Abstract] [Full Text] [Related]
6. Tfm-AR modulates the effects of ApoE4 on cognition.
Rizk-Jackson A; Robertson J; Raber J
J Neurochem; 2008 Apr; 105(1):63-7. PubMed ID: 18039320
[TBL] [Abstract][Full Text] [Related]
7. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical effects of apolipoprotein E on cognitive function and clinical progression in mice with experimental autoimmune encephalomyelitis.
Dayger CA; Rosenberg JS; Winkler C; Foster S; Witkowski E; Benice TS; Sherman LS; Raber J
Pharmacol Biochem Behav; 2013 Feb; 103(4):860-8. PubMed ID: 23201649
[TBL] [Abstract][Full Text] [Related]
9. MS and cognition and APOE: the ongoing conundrum about biomarkers.
Sadovnick AD; Jacobs DH
Neurology; 2008 Jan; 70(3):164-5. PubMed ID: 18195261
[No Abstract] [Full Text] [Related]
10. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
11. APOE genotype modulates the effect of serum calcium levels on cognitive function in old age.
van Vliet P; Oleksik AM; Mooijaart SP; de Craen AJ; Westendorp RG
Neurology; 2009 Mar; 72(9):821-8. PubMed ID: 19255409
[TBL] [Abstract][Full Text] [Related]
12. Association between ApoE epsilon4 and cognitive impairment after stroke.
Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and cognitive studies of apolipoprotein-E-deficient mice.
Gordon I; Genis I; Grauer E; Sehayek E; Michaelson DM
Mol Chem Neuropathol; 1996; 28(1-3):97-103. PubMed ID: 8871947
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment in neurological diseases: lessons from apolipoprotein E.
Shi J; Han P; Kuniyoshi SM
J Alzheimers Dis; 2014; 38(1):1-9. PubMed ID: 23948926
[TBL] [Abstract][Full Text] [Related]
16. APOE epsilon4 and cognitive dysfunction in multiple sclerosis: a review.
Ghaffar O; Feinstein A
J Neuropsychiatry Clin Neurosci; 2010; 22(2):155-65. PubMed ID: 20463109
[TBL] [Abstract][Full Text] [Related]
17. ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis.
Portaccio E; Zipoli V; Goretti B; Hakiki B; Nacmias B; Siracusa G; Sorbi S; Amato MP
Acta Neurol Scand; 2009 Dec; 120(6):439-41. PubMed ID: 19804477
[TBL] [Abstract][Full Text] [Related]
18. Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis.
Lavrnja I; Bjelobaba I; Stojiljkovic M; Pekovic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Nedeljkovic N
Neurochem Int; 2009 Sep; 55(4):193-8. PubMed ID: 19524108
[TBL] [Abstract][Full Text] [Related]
19. Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS.
Schrewe L; Lill CM; Liu T; Salmen A; Gerdes LA; Guillot-Noel L; Akkad DA; Blaschke P; Graetz C; Hoffjan S; Kroner A; Demir S; Böhme A; Rieckmann P; ElAli A; Hagemann N; Hermann DM; Cournu-Rebeix I; Zipp F; Kümpfel T; Buttmann M; Zettl UK; Fontaine B; Bertram L; Gold R; Chan A
J Neuroinflammation; 2015 Dec; 12():234. PubMed ID: 26669675
[TBL] [Abstract][Full Text] [Related]
20. Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis.
Reyes-Irisarri E; Sánchez AJ; García-Merino JA; Mengod G
J Neuropathol Exp Neurol; 2007 Oct; 66(10):923-31. PubMed ID: 17917586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
